Our additional test on TP53-mutant HCC cells suggests that the induction of RRM2B in liver cancer cells is likely p53-dependent, as we did not observe an RRM2 to RRM2B switching in TP53-mutant HCC cell lines. The gene discussed is RRM2; the disease is hepatocellular carcinoma.